Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Kidney Transplantation

  Free Subscription

Articles published in Kidney Int

Retrieve available abstracts of 188 articles:
HTML format

Single Articles

    July 2021
  1. TAMBUR AR, Kosmoliaptsis V, Claas FH, Mannon RB, et al
    Significance of HLA-DQ in kidney transplantation - Time to re-evaluate HLA matching priorities to improve transplant outcomes? An expert review and recommendations.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00657.
    PubMed     Abstract available

  2. DALOUL R, Pesavento T, Goldberg DS, Reese PP, et al
    A Review of kidney transplantation from HCV-Viremic Donors into Negative Recipients.
    Kidney Int. 2021 Jul 5. pii: S0085-2538(21)00669.
    PubMed     Abstract available

    APOL1 genotyping in kidney transplantation: a look into the future.
    Kidney Int. 2021;100:32-34.

  4. KUMAR V, Locke JE
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
    Kidney Int. 2021;100:30-32.

  5. FREEDMAN BI, Poggio ED
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
    Kidney Int. 2021;100:27-30.

  6. YAMADA M, Iwamoto H, Konno O, Kihara Y, et al
    Pelvic arteriovenous malformation in a kidney transplant recipient.
    Kidney Int. 2021;100:246.

  7. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
    Kidney Int. 2021;100:243.

    June 2021
  8. IKIZLER TA, Coates PT, Rovin BH, Ronco P, et al
    Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
    Kidney Int. 2021;99:1275-1279.
    PubMed     Abstract available

  9. RAMSPEK CL, El Moumni M, Wali E, Heemskerk MBA, et al
    Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation.
    Kidney Int. 2021;99:1459-1469.
    PubMed     Abstract available

    May 2021
  10. DOLFF S, Baotong Z, Korth J, De L, et al
    Evidence of Cell Mediated Immune response in kidney transplants with negative mRNA-1273 Antibody Response.
    Kidney Int. 2021 May 21. pii: S0085-2538(21)00511.

  11. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.

  12. LIANG EN W, Tan CS, Conceicao EP, Venkatachalam I, et al
    Zero health care-associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic.
    Kidney Int. 2021;99:1236-1238.

  13. SOTOMAYOR CG, Groothof D, Vodegel JJ, Eisenga MF, et al
    Plasma cadmium is associated with increased risk of long-term kidney graft failure.
    Kidney Int. 2021;99:1213-1224.
    PubMed     Abstract available

  14. DUJARDIN A, Lorent M, Foucher Y, Legendre C, et al
    Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death.
    Kidney Int. 2021;99:1189-1201.
    PubMed     Abstract available

    April 2021
  15. CHANG CC, Vlad G, Vasilescu ER, Husain SA, et al
    Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00457.

  16. PUTTARAJAPPA CM, Jorgensen D, Yabes JG, Jeong K, et al
    Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00460.
    PubMed     Abstract available

  17. DEL BELLO A, Marion O, Delas A, Congy-Jolivet N, et al
    Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00466.

  18. CLAUDIO P, Rosaria CM
    The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00454.
    PubMed     Abstract available

  19. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00389.

  20. COOREY CP, Sharma A, Muller S, Yang JYH, et al
    Prediction modeling-part 2: using machine learning strategies to improve transplantation outcomes.
    Kidney Int. 2021;99:817-823.
    PubMed     Abstract available

    March 2021
  21. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Mar 25. pii: S0085-2538(21)00348.

  22. NIMMO A, Ravanan R, Taylor DM
    The authors reply.
    Kidney Int. 2021;99:772-773.

  23. DUCLOUX D, Rebibou JM, Courivaud C
    Pretransplant coronary artery disease screening is still valid.
    Kidney Int. 2021;99:772.

  24. ROBSON KJ, Kitching AR
    Recurrent membranous nephropathy after transplantation: donor antigen and HLA converge in defining risk.
    Kidney Int. 2021;99:545-548.
    PubMed     Abstract available

    February 2021
  25. KOO TY, Lee JH, Min SI, Lee Y, et al
    Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.
    Kidney Int. 2021 Feb 26. pii: S0085-2538(21)00258.
    PubMed     Abstract available

  26. CHAVAROT N, Leruez-Ville M, Scemla A, Burger C, et al
    Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.
    Kidney Int. 2021;99:486-488.

  27. RANKIN AJ, Mark PB
    Cardiac screening prior to renal transplantation-good intentions, rather than good evidence, dictate practice.
    Kidney Int. 2021;99:306-308.
    PubMed     Abstract available

    January 2021
  28. CHAVAROT N, Burger C, Aguilar C, Scemla A, et al
    Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.
    Kidney Int. 2021 Jan 22. pii: S0085-2538(20)31552.

  29. THAUNAT O, Legeai C, Bastien O, Caillard S, et al
    Response to "On the need to better protect hemodialysis patients. A comment on the IMPORTANT study": one more IMPORTANT thing!
    Kidney Int. 2021 Jan 10. pii: S0085-2538(20)31527.

  30. MASSIMO T, Hafedh F, Barbara PG
    On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Kidney Int. 2021 Jan 9. pii: S0085-2538(20)31525.

  31. VINSON AJ, Chong AS, Clegg D, Falk C, et al
    Kidney Int. 2021 Jan 4. pii: S0085-2538(20)31545.

  32. DINH A, McCulloch CE, Ku E
    Predicting long-term kidney allograft outcomes: pitfalls and progress.
    Kidney Int. 2021;99:24-26.
    PubMed     Abstract available

    December 2020
  33. MURAKAMI N, Mulvaney P, Danesh M, Abudayyeh A, et al
    A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
    Kidney Int. 2020 Dec 23. pii: S0085-2538(20)31534.
    PubMed     Abstract available

  34. STEL VS, de Jong RW, Kramer A, Andrusev AM, et al
    Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe.
    Kidney Int. 2020 Dec 21. pii: S0085-2538(20)31529.
    PubMed     Abstract available

  35. MALYSZKO J, Bamias A, Danesh FR, Debska-Slizien A, et al
    KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation.
    Kidney Int. 2020;98:1407-1418.
    PubMed     Abstract available

  36. CLARK EG, Knoll G
    More than ever, efficient evaluation of potential living kidney donors is needed.
    Kidney Int. 2020;98:1395-1397.
    PubMed     Abstract available

  37. SOFTELAND JM, Karason K, Magnusson J, Schult A, et al
    Registry reports in COVID-19 patients: juggling with big data, poor data, and no data.
    Kidney Int. 2020;98:1618.

  38. HAZZAN M, Caillard S
    The authors reply.
    Kidney Int. 2020;98:1618-1619.

    November 2020
  39. NIMMO A, Forsyth J, Oniscu G, Robb M, et al
    A propensity score matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients.
    Kidney Int. 2020 Nov 7. pii: S0085-2538(20)31258.
    PubMed     Abstract available

  40. BLOSSER CD, Haber G, Engels EA
    Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period.
    Kidney Int. 2020 Nov 4. pii: S0085-2538(20)31257.
    PubMed     Abstract available

  41. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.

    October 2020
  42. THAUNAT O, Legeai C, Anglicheau D, Couzi L, et al
    IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT).
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31206.
    PubMed     Abstract available

  43. DUJARDIN A, Chesneau M, Dubois F, Danger R, et al
    Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes.
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31247.
    PubMed     Abstract available

    A Kidney International "Journal of the COVID-19 Year" in Kidney Transplantation.
    Kidney Int. 2020 Oct 19. pii: S0085-2538(20)31204.

  45. AZZI Y, Parides M, Alani O, Loarte-Campos P, et al
    COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.
    Kidney Int. 2020 Oct 15. pii: S0085-2538(20)31202.
    PubMed     Abstract available

  46. GADE AR, Alavala H, Allam SR
    Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
    Kidney Int. 2020;98:1054.

    September 2020
  47. JAGER KJ, Kramer A, Chesnaye NC, Couchoud C, et al
    Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
    Kidney Int. 2020 Sep 23. pii: S0085-2538(20)31081.
    PubMed     Abstract available

  48. SINGH N, Tandukar S, Zibari G, Naseer MS, et al
    Successful Simultaneous Pancreas and Kidney Transplant in a Patient Post-COVID-19 Infection.
    Kidney Int. 2020 Sep 15. pii: S0085-2538(20)31079.

  49. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
    Kidney Int. 2020 Sep 1. pii: S0085-2538(20)30967.
    PubMed     Abstract available

    August 2020
  50. CAILLARD S, Anglicheau D, Matignon M, Durrbach A, et al
    An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants.
    Kidney Int. 2020 Aug 24. pii: S0085-2538(20)30961.
    PubMed     Abstract available

  51. KNOLL GA, Fortin MC, Gill J, Grimshaw JM, et al
    Measuring Quality in Living Donation and Kidney Transplantation: Moving Beyond Survival Metrics.
    Kidney Int. 2020 Aug 10. pii: S0085-2538(20)30906.

  52. RAYNAUD M, Aubert O, Reese PP, Bouatou Y, et al
    Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
    Kidney Int. 2020 Aug 8. pii: S0085-2538(20)30937.
    PubMed     Abstract available

  53. BONTHUIS M, Cuperus L, Chesnaye NC, Akman S, et al
    Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.
    Kidney Int. 2020;98:464-475.
    PubMed     Abstract available

    The meaning of borderline rejection in kidney transplantation.
    Kidney Int. 2020;98:278-280.
    PubMed     Abstract available

  55. COATES PT, Wong G
    The forgotten fallen: painful reality of a pandemic.
    Kidney Int. 2020;98:251-252.

  56. AZIZ F, Muth B, Parajuli S, Garg N, et al
    Unusually high rates of acute rejection during the COVID-19 pandemic: cause for concern?
    Kidney Int. 2020;98:513-514.

  57. CHERUKURI A, Mehta R, Sharma A, Sood P, et al
    The authors reply.
    Kidney Int. 2020;98:516.

  58. YIN S
    Post-transplant donor-specific antibody and outcomes with T cell-mediated rejection and nonadherence.
    Kidney Int. 2020;98:515-516.

    July 2020
  59. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
    Kidney Int. 2020 Jul 23. pii: S0085-2538(20)30830.
    PubMed     Abstract available

  60. KIM J, Perkins GB, Coates PT
    Evolutionary immunology: how your ancestry can affect your kidney transplant.
    Kidney Int. 2020;98:45-47.

    June 2020
  61. LEE J, Huh KH
    Kidney transplantation trends in South Korea during the COVID-19 pandemic.
    Kidney Int. 2020 Jun 19. pii: S0085-2538(20)30692.

  62. FERNANDEZ-RUIZ M, Seron D, Alonso A, Lora D, et al
    Derivation and external validation of the SIMPLICITY Score as a simple immune-based risk score to predict infection in kidney transplant recipients.
    Kidney Int. 2020 Jun 12. pii: S0085-2538(20)30638.
    PubMed     Abstract available

  63. GAUTIER-VARGAS G, Baldacini C, Benotmane I, Keller N, et al
    Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30622.

  64. KEMMNER S, Guba M, Schonermarck U, Stangl M, et al
    Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30628.

  65. ELENBERG E, O'Mahony CA, Eldin KW
    Ruptured gallbladder in cystinosis renal transplant recipient.
    Kidney Int. 2020;97:1304.

  66. GOMEZ-ALDANA A, Tapias M, Rosselli D
    Opt-out in kidney transplantation rates: the Colombian experience.
    Kidney Int. 2020;97:1299.

    May 2020
  67. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available

    April 2020
  68. MEHTA RB, Tandukar S, Jorgensen D, Randhawa P, et al
    Early subclinical tubulitis and interstitial inflammation in kidney transplantation have adverse clinical implications.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30408.
    PubMed     Abstract available

  69. SHIM YJ, Khedraki R, Dhar J, Fan R, et al
    Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30430.
    PubMed     Abstract available

  70. BANERJEE D, Popoola J, Shah S, Ster IC, et al
    COVID-19 infection in kidney transplant recipients.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30361.
    PubMed     Abstract available

  71. COATES PT, Wong G, Drueke T, Rovin B, et al
    Early experience with COVID-19 in kidney transplantation.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30362.

  72. ALBERICI F, Delbarba E, Manenti C, Econimo L, et al
    A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30365.
    PubMed     Abstract available

  73. ROSSI M, L'Imperio V, Garces J, Fogo AB, et al
    The Case | Acute kidney injury after liver and kidney transplantation.
    Kidney Int. 2020;97:813-814.

  74. HEIDT S, Claas FHJ
    Not all HLA epitope mismatches are equal.
    Kidney Int. 2020;97:653-655.
    PubMed     Abstract available

    February 2020
  75. DE KOK MJ, Schaapherder AF, Mensink JW, de Vries AP, et al
    A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss.
    Kidney Int. 2020 Feb 29. pii: S0085-2538(20)30224.
    PubMed     Abstract available

  76. DANGI A, Yu S, Lee FT, Burnette M, et al
    Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.
    Kidney Int. 2020 Feb 21. pii: S0085-2538(20)30151.
    PubMed     Abstract available

  77. JACOBS SE, Kirou KA, Seshan SV, Walsh TJ, et al
    The Case | Knee pain and allograft dysfunction in a kidney transplant recipient.
    Kidney Int. 2020;97:429-430.

    January 2020
  78. ALLAM SR, Madhrira MM, Memon IA, Tessier J, et al
    Invasive mucormycosis in a renal transplant recipient.
    Kidney Int. 2020;97:216.

    Arteriovenous fistulas in patients with kidney transplantation.
    Kidney Int. 2020;97:20-21.

  80. SIGOGNE M, Culty T, Meria P, Demiselle J, et al
    Encrusted pyelitis in a kidney allograft.
    Kidney Int. 2020;97:217.

  81. PERAZELLA MA, Shirali AC
    Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
    Kidney Int. 2020;97:62-74.
    PubMed     Abstract available

    December 2019
  82. KAGAN I, McDonald ML, Gritsch HA, Yabu JM, et al
    Kidney transplantation utilizing a horseshoe kidney.
    Kidney Int. 2019;96:1427.

    Prediabetes after kidney transplantation-a reason to worry?
    Kidney Int. 2019;96:1280-1282.
    PubMed     Abstract available

    November 2019
  84. SAPIR-PICHHADZE R, Zhang X, Ferradji A, Madbouly A, et al
    Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Kidney Int. 2019 Nov 12. pii: S0085-2538(19)31132.
    PubMed     Abstract available

  85. LASTER M, Pereira RC, Salusky IB
    Unraveling the osteocyte in CKD-MBD post-renal transplantation.
    Kidney Int. 2019;96:1059-1061.
    PubMed     Abstract available

  86. SCHMIDT-LAUBER C, Buttner-Herold M, Schiffer M, Wiesener MS, et al
    Tuberculous granulomatous interstitial nephritis in a renal allograft.
    Kidney Int. 2019;96:1243.

    October 2019
  87. BANE O, Hectors SJ, Gordic S, Kennedy P, et al
    Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis.
    Kidney Int. 2019 Oct 30. pii: S0085-2538(19)31038.
    PubMed     Abstract available

  88. SEKAR P, West BL, Henriksen KJ, Chang A, et al
    An incidental but pathognomonic finding in renal allograft biopsy.
    Kidney Int. 2019;96:1042.

    September 2019
  89. PEDERSEN MS, Muller M, Rulicke T, Leitner N, et al
    Lymphangiogenesis in a mouse model of renal transplant rejection extends life span of the recipients.
    Kidney Int. 2019 Sep 3. pii: S0085-2538(19)30843.
    PubMed     Abstract available

  90. Angel-Korman A, Stern L, Sarosiek S, et al. Long-term outcome of kidney transplantation in AL amyloidosis. Kidney Int. 2019;95:405-411.
    Kidney Int. 2019;96:796.

    August 2019
  91. PORRINI E, Diaz JM, Moreso F, Lauzurrica R, et al
    Prediabetes is a risk factor for cardiovascular disease following renal transplantation.
    Kidney Int. 2019 Aug 14. pii: S0085-2538(19)30810.
    PubMed     Abstract available

  92. DUPONT V, Colosio C, Hureaux M, Mokri L, et al
    The Case | Severe hypertension and hyperkalemia in a kidney transplant recipient.
    Kidney Int. 2019;96:529-530.

  93. PHILIP NM, Naranje P, Bagchi S, Das CJ, et al
    Multiple abscesses in a renal transplant recipient.
    Kidney Int. 2019;96:526.

    July 2019
  94. CHADBAN S, Tedesco-Silva H
    ATHENA: wisdom and warfare in defining the role of de novo mTOR inhibition in kidney transplantation.
    Kidney Int. 2019;96:27-30.
    PubMed     Abstract available

  95. KAUNDAL U, Ramachandran R, Arora A, Kenwar DB, et al
    B cells: a new player in mesenchymal stromal cell-mediated immune modulation in renal transplant patients.
    Kidney Int. 2019;96:249-250.

    June 2019
  96. ARAUJO MJCLN, Bacelar Marques ID, Graciolli FG, Fukuhara L, et al
    Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin.
    Kidney Int. 2019 Jun 25. pii: S0085-2538(19)30626.
    PubMed     Abstract available

  97. RANGASWAMI J, Bangalore S, Kaplan B, Birdwell KA, et al
    Cardiovascular disease care fragmentation in kidney transplantation: a call for action.
    Kidney Int. 2019 Jun 10. pii: S0085-2538(19)30586.

    May 2019
  98. DRIOLLET B, Bayer F, Chatelet V, Macher MA, et al
    Social deprivation is associated with poor kidney transplantation outcome in children.
    Kidney Int. 2019 May 28. pii: S0085-2538(19)30530.
    PubMed     Abstract available

  99. LEE LOY J, Koratala A, De Los Santos Y, Chamarthi G, et al
    Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis.
    Kidney Int. 2019;95:1274.

    April 2019
  100. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Abstract available

  101. NASR SH, Fogo AB
    New developments in the diagnosis of fibrillary glomerulonephritis.
    Kidney Int. 2019 Apr 9. pii: S0085-2538(19)30407.
    PubMed     Abstract available

  102. FORMAN C, Sran H, Wafi A
    Delayed stricture of irradiated iliac arteries after renal transplantation mimicking transplant renal artery stenosis.
    Kidney Int. 2019;95:999.

  103. D'AMBROSIO R, Vinci M, Franchina M, Parlati L, et al
    Effectiveness and safety of sofosbuvir-based direct-acting antiviral combinations in HCV-2 and HCV-3 kidney transplant recipients.
    Kidney Int. 2019;95:993-995.

  104. BARBOUR S, Djurdjev O, Gill JS, Dong JJ, et al
    A propensity score matched analysis shows no adverse effect of early steroid withdrawal in non-diabetic kidney transplant recipients with and without glomerulonephritis.
    Kidney Int. 2019 Apr 1. pii: S0085-2538(19)30388.
    PubMed     Abstract available

    Evaluation of living donors: quo vadis for GFR criteria?
    Kidney Int. 2019;95:738-740.
    PubMed     Abstract available

  106. SINGH G, Swamy A, Kumari K, Brijwal M, et al
    The Case | Mass in nonfunctioning first renal allograft in a recipient of 2 transplant kidneys.
    Kidney Int. 2019;95:1001-1002.

  107. GAILLARD F, Courbebaisse M, Kamar N, Rostaing L, et al
    Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors.
    Kidney Int. 2019;95:896-904.
    PubMed     Abstract available

  108. LEIBLER C, Thiolat A, Elsner RA, El Karoui K, et al
    Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.
    Kidney Int. 2019;95:774-786.
    PubMed     Abstract available

    March 2019
  109. TAYLOR DM, Bradley JA, Bradley C, Draper H, et al
    Limited health literacy is associated with reduced access to kidney transplantation.
    Kidney Int. 2019 Mar 27. pii: S0085-2538(19)30049.
    PubMed     Abstract available

  110. CHERUKURI A, Mehta R, Sharma A, Sood P, et al
    Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30176.
    PubMed     Abstract available

  111. FU R, Kim SJ, de Oliveira C, Coyte PC, et al
    An instrumental variable approach quantifies and confirms the duration of pre-transplant dialysis has negative impact on kidney transplant recipient survival.
    Kidney Int. 2019 Mar 19. pii: S0085-2538(19)30323.
    PubMed     Abstract available

  112. LEFAUCHEUR C, Viglietti D, Bouatou Y, Philippe A, et al
    Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30173.
    PubMed     Abstract available

  113. OTTLEWSKI I, Munch J, Wagner T, Schonauer R, et al
    Value of renal gene panel diagnostics in adults waiting for kidney transplantation due to undetermined end-stage renal disease.
    Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30187.
    PubMed     Abstract available

  114. SNANOUDJ R, Kamar N, Cassuto E, Caillard S, et al
    Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.
    Kidney Int. 2019 Mar 5. pii: S0085-2538(19)30115.
    PubMed     Abstract available

  115. EVENEPOEL P, Claes K, Meijers B, Laurent MR, et al
    Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
    Kidney Int. 2019 Mar 4. pii: S0085-2538(19)30105.
    PubMed     Abstract available

  116. BRUNEL M, Leclerc-Mercier S, Barnier JP, Bille E, et al
    The Case | Posttransplant upper limb inflammatory nodules.
    Kidney Int. 2019;95:721-722.

  117. WANG F, Yang C, Long J, Zhao X, et al
    Executive summary for the 2015 Annual Data Report of the China Kidney Disease Network (CK-NET).
    Kidney Int. 2019;95:501-505.
    PubMed     Abstract available

  118. SRIVASTAVA P, Solanki AK, Arif E, Wolf BJ, et al
    Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients.
    Kidney Int. 2019;95:708-716.
    PubMed     Abstract available

  119. LI J, Koerner J, Basler M, Brunner T, et al
    Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.
    Kidney Int. 2019;95:611-623.
    PubMed     Abstract available

    February 2019
  120. FRIBOURG M, Anderson L, Fischman C, Cantarelli C, et al
    T-cell exhaustion correlates with improved outcomes in kidney transplant recipients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30192.
    PubMed     Abstract available

  121. SOMMERER C, Suwelack B, Dragun D, Schenker P, et al
    An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Kidney Int. 2019 Feb 27. pii: S0085-2538(19)30193.
    PubMed     Abstract available

  122. WEWERS TM, Mayer AB, Pfleiderer A, Beul K, et al
    Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Kidney Int. 2019 Feb 22. pii: S0085-2538(18)30901.
    PubMed     Abstract available

  123. NUVOLONE M, Merlini G
    Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice.
    Kidney Int. 2019;95:258-260.
    PubMed     Abstract available

  124. SUMMERS DM, Pettigrew GJ
    Uncontrolled DCD donation-tilting at windmills or pushing against an open door?
    Kidney Int. 2019;95:263-265.
    PubMed     Abstract available

  125. YAGISAWA T, Tanaka T, Miyairi S, Tanabe K, et al
    In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Kidney Int. 2019;95:350-362.
    PubMed     Abstract available

    January 2019
  126. SMITH SF, Hosgood SA, Nicholson ML
    Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.
    Kidney Int. 2019;95:50-56.
    PubMed     Abstract available

  127. DOTIS J, Printza N, Stabouli S, Karava V, et al
    Disseminated mucormycosis in an adolescent kidney transplant recipient.
    Kidney Int. 2019;95:236.

  128. EVERSON L, Bernstein BS, Chatterjee D, Lindsey B, et al
    ThINK before living donor transplantation.
    Kidney Int. 2019;95:237.

  129. HALL IE, Akalin E, Bromberg JS, Doshi MD, et al
    Deceased-donor acute kidney injury is not associated with kidney allograft failure.
    Kidney Int. 2019;95:199-209.
    PubMed     Abstract available

    December 2018
  130. ANGEL-KORMAN A, Stern L, Sarosiek S, Sloan JM, et al
    Long-term outcome of kidney transplantation in AL amyloidosis.
    Kidney Int. 2018 Dec 20. pii: S0085-2538(18)30774.
    PubMed     Abstract available

  131. DEL RIO F, Andres A, Padilla M, Sanchez-Fructuoso AI, et al
    Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience.
    Kidney Int. 2018 Dec 19. pii: S0085-2538(18)30717.
    PubMed     Abstract available

  132. ERPICUM P, Weekers L, Detry O, Bonvoisin C, et al
    Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Kidney Int. 2018 Dec 6. pii: S0085-2538(18)30712.
    PubMed     Abstract available

  133. KOPP JB
    Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
    Kidney Int. 2018;94:1048-1050.
    PubMed     Abstract available

  134. SAMPATHKUMAR K, Mukuntharajan T, Rajiv A, Anandan S, et al
    Acute page kidney phenomenon following renal allograft biopsy.
    Kidney Int. 2018;94:1241.

    November 2018
  135. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Abstract available

  136. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Abstract available

  137. JARDINE AG, Hartmann A, Holdaas H
    Long-term renal allograft survival: a quiet revolution.
    Kidney Int. 2018;94:853-855.
    PubMed     Abstract available

    October 2018
  138. SANTORIELLO D, Husain SA, De Serres SA, Bomback AS, et al
    Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Kidney Int. 2018 Oct 2. pii: S0085-2538(18)30481.
    PubMed     Abstract available

  139. COZZI E, Biancone L
    C1q-binding donor-specific antibody assays help define risk and prognosis in antibody-mediated rejection.
    Kidney Int. 2018;94:657-659.
    PubMed     Abstract available

    September 2018
  140. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Abstract available

    August 2018
  141. FRANCIS A, Johnson DW, Craig J, Teixeira-Pinto A, et al
    Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30446.
    PubMed     Abstract available

    July 2018
  142. COEMANS M, Susal C, Dohler B, Anglicheau D, et al
    Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30392.
    PubMed     Abstract available

    June 2018
  143. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Abstract available

    May 2018
  144. KOPP JB
    Global glomerulosclerosis in primary nephrotic syndrome: including age as a variable to predict renal outcomes.
    Kidney Int. 2018;93:1043-1044.
    PubMed     Abstract available

  145. NADA R, Ramachandran R, Kumar A, Gupta KL, et al
    Tumoral masses in failed kidneys.
    Kidney Int. 2018;93:1253.

    April 2018
  146. SAID SM, Cosio FG, Valeri AM, Leung N, et al
    Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft.
    Kidney Int. 2018 Apr 28. pii: S0085-2538(18)30175.
    PubMed     Abstract available

  147. TANER T, Gustafson MP, Hansen MJ, Park WD, et al
    Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30135.
    PubMed     Abstract available

    March 2018
  148. BATAL I, Mohan S, De Serres SA, Vasilescu ER, et al
    Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Kidney Int. 2018 Mar 13. pii: S0085-2538(18)30059.
    PubMed     Abstract available

  149. GREENLEAF E, Farooq U, Jain A, DiCristina R, et al
    Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient.
    Kidney Int. 2018;93:762.

  150. SIVAYOGANATHAN S, Ariyawansa D, Ambawatte P, Galahitiyawa C, et al
    A rare presentation of a posttransplant lymphoproliferative disorder.
    Kidney Int. 2018;93:761.

    February 2018
  151. DURAND M, Dubois F, Dejou C, Durand E, et al
    Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(18)30001.
    PubMed     Abstract available

  152. REICH B, Viehmann SF, Kurts C
    Plasmacytoid dendritic cells: important players in human kidney allograft rejection.
    Kidney Int. 2018;93:301-303.
    PubMed     Abstract available

  153. RUBEN JM, Garcia-Romo GS, Breman E, van der Kooij S, et al
    Human plasmacytoid dendritic cells acquire phagocytic capacity by TLR9 ligation in the presence of soluble factors produced by renal epithelial cells.
    Kidney Int. 2018;93:355-364.
    PubMed     Abstract available

  154. HEIDT S, Haasnoot GW, van Rood JJ, Witvliet MD, et al
    Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Kidney Int. 2018;93:491-500.
    PubMed     Abstract available

    January 2018
  155. CHUTE DF, Chung RT, Sise ME
    Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30807.
    PubMed     Abstract available

  156. RODELO-HAAD C, Aguera ML, Ortega R, Martinez-Lopez A, et al
    Lithium-associated nephropathy in the renal allograft.
    Kidney Int. 2018;93:273.

  157. ETTA PK, Rao MV
    Gas in a renal allograft: think beyond!
    Kidney Int. 2018;93:272.

    December 2017
  158. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Abstract available

    October 2017
  159. LIM WH, Wong G, Heidt S, Claas FHJ, et al
    Novel aspects of epitope matching and practical application in kidney transplantation.
    Kidney Int. 2017 Oct 20. pii: S0085-2538(17)30604.
    PubMed     Abstract available

    September 2017
  160. YACOUB R, Nadkarni GN, Cravedi P, He JC, et al
    Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Kidney Int. 2017 Sep 28. pii: S0085-2538(17)30547.
    PubMed     Abstract available

  161. PEARL MH, Zhang Q, Palma Diaz MF, Grotts J, et al
    Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Kidney Int. 2017 Sep 16. pii: S0085-2538(17)30509.
    PubMed     Abstract available

  162. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    PubMed     Abstract available

    August 2017
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Abstract available

    July 2017
  164. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Abstract available

  165. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    PubMed     Abstract available

    June 2017
  166. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Abstract available

  167. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Abstract available

    May 2017
  168. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Abstract available

  169. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.

    April 2017
  170. GILL J, Rose C, Joffres Y, Kadatz M, et al
    Cold ischemia time up to 16 hours has little impact on living donor kidney transplant outcomes in the era of kidney paired donation.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30105.
    PubMed     Abstract available

  171. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Abstract available

  172. NADKARNI GN, Wyatt CM, Murphy B, Ross MJ, et al
    APOL1: a case in point for replacing race with genetics.
    Kidney Int. 2017;91:768-770.
    PubMed     Abstract available

  173. WIJKSTROM M, Iwase H, Paris W, Hara H, et al
    Renal xenotransplantation: experimental progress and clinical prospects.
    Kidney Int. 2017;91:790-796.
    PubMed     Abstract available

    March 2017
  174. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Abstract available

  175. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Abstract available

  176. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Abstract available

  177. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Abstract available

    February 2017
  178. SHIU KY, McLaughlin L, Rebollo-Mesa I, Zhao J, et al
    Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells.
    Kidney Int. 2017;91:477-492.
    PubMed     Abstract available

    January 2017
  179. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Abstract available

    December 2016
  180. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Abstract available

  181. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Abstract available

    October 2016
  182. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Abstract available

    August 2016
  183. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Abstract available

    June 2016
  184. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.

    May 2016
  185. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Abstract available

  186. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Abstract available

  187. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Abstract available

    April 2016
  188. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.